Cargando…

Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms

A subset of victims of ocular sulfur mustard (SM) exposure develops an irreversible, idiotypic keratitis with associated secondary pathologies, collectively referred to as mustard gas keratopathy (MGK). MGK involves a progressive corneal degeneration resulting in chronic ocular discomfort and impair...

Descripción completa

Detalles Bibliográficos
Autores principales: McNutt, Patrick, Lyman, Megan, Swartz, Adam, Tuznik, Kaylie, Kniffin, Denise, Whitten, Kim, Milhorn, Denise, Hamilton, Tracey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416783/
https://www.ncbi.nlm.nih.gov/pubmed/22900056
http://dx.doi.org/10.1371/journal.pone.0042837
_version_ 1782240444330016768
author McNutt, Patrick
Lyman, Megan
Swartz, Adam
Tuznik, Kaylie
Kniffin, Denise
Whitten, Kim
Milhorn, Denise
Hamilton, Tracey
author_facet McNutt, Patrick
Lyman, Megan
Swartz, Adam
Tuznik, Kaylie
Kniffin, Denise
Whitten, Kim
Milhorn, Denise
Hamilton, Tracey
author_sort McNutt, Patrick
collection PubMed
description A subset of victims of ocular sulfur mustard (SM) exposure develops an irreversible, idiotypic keratitis with associated secondary pathologies, collectively referred to as mustard gas keratopathy (MGK). MGK involves a progressive corneal degeneration resulting in chronic ocular discomfort and impaired vision for which clinical interventions have typically had poor outcomes. Using a rabbit corneal vapor exposure model, we previously demonstrated a clinical progression with acute and chronic sequelae similar to that observed in human casualties. However, a better understanding of the temporal changes that occur during the biphasic SM injury is crucial to mechanistic understanding and therapeutic development. Here we evaluate the histopathologic, biochemical and ultrastructural expressions of pathogenesis of the chronic SM injury over eight weeks. We confirm that MGK onset exhibits a biphasic trajectory involving corneal surface regeneration over the first two weeks, followed by the rapid development and progressive degeneration of corneal structure. Preclinical markers of corneal dysfunction were identified, including destabilization of the basal corneal epithelium, basement membrane zone abnormalities and stromal deformation. Clinical sequelae of MGK appeared abruptly three weeks after exposure, and included profound anterior edema, recurring corneal erosions, basement membrane disorganization, basal cell necrosis and stromal degeneration. Unlike resolved corneas, MGK corneas exhibited frustrated corneal wound repair, with significantly elevated histopathology scores. Increased lacrimation, disruption of the basement membrane and accumulation of pro-inflammatory mediators in the aqueous humor provide several mechanisms for corneal degeneration. These data suggest that the chronic injury is fundamentally distinct from the acute lesion, involving injury mechanisms that operate on different time scales and in different corneal tissues. Corneal edema appears to be the principal pathology of MGK, in part resulting from persistent necrosis of the basal corneal epithelium and deterioration of the basement membrane. The findings also provide a potential explanation as to why administration of anti-inflammatories transiently delays, but does not prevent, the development of MGK sequelae.
format Online
Article
Text
id pubmed-3416783
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34167832012-08-16 Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms McNutt, Patrick Lyman, Megan Swartz, Adam Tuznik, Kaylie Kniffin, Denise Whitten, Kim Milhorn, Denise Hamilton, Tracey PLoS One Research Article A subset of victims of ocular sulfur mustard (SM) exposure develops an irreversible, idiotypic keratitis with associated secondary pathologies, collectively referred to as mustard gas keratopathy (MGK). MGK involves a progressive corneal degeneration resulting in chronic ocular discomfort and impaired vision for which clinical interventions have typically had poor outcomes. Using a rabbit corneal vapor exposure model, we previously demonstrated a clinical progression with acute and chronic sequelae similar to that observed in human casualties. However, a better understanding of the temporal changes that occur during the biphasic SM injury is crucial to mechanistic understanding and therapeutic development. Here we evaluate the histopathologic, biochemical and ultrastructural expressions of pathogenesis of the chronic SM injury over eight weeks. We confirm that MGK onset exhibits a biphasic trajectory involving corneal surface regeneration over the first two weeks, followed by the rapid development and progressive degeneration of corneal structure. Preclinical markers of corneal dysfunction were identified, including destabilization of the basal corneal epithelium, basement membrane zone abnormalities and stromal deformation. Clinical sequelae of MGK appeared abruptly three weeks after exposure, and included profound anterior edema, recurring corneal erosions, basement membrane disorganization, basal cell necrosis and stromal degeneration. Unlike resolved corneas, MGK corneas exhibited frustrated corneal wound repair, with significantly elevated histopathology scores. Increased lacrimation, disruption of the basement membrane and accumulation of pro-inflammatory mediators in the aqueous humor provide several mechanisms for corneal degeneration. These data suggest that the chronic injury is fundamentally distinct from the acute lesion, involving injury mechanisms that operate on different time scales and in different corneal tissues. Corneal edema appears to be the principal pathology of MGK, in part resulting from persistent necrosis of the basal corneal epithelium and deterioration of the basement membrane. The findings also provide a potential explanation as to why administration of anti-inflammatories transiently delays, but does not prevent, the development of MGK sequelae. Public Library of Science 2012-08-10 /pmc/articles/PMC3416783/ /pubmed/22900056 http://dx.doi.org/10.1371/journal.pone.0042837 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
McNutt, Patrick
Lyman, Megan
Swartz, Adam
Tuznik, Kaylie
Kniffin, Denise
Whitten, Kim
Milhorn, Denise
Hamilton, Tracey
Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
title Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
title_full Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
title_fullStr Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
title_full_unstemmed Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
title_short Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
title_sort architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416783/
https://www.ncbi.nlm.nih.gov/pubmed/22900056
http://dx.doi.org/10.1371/journal.pone.0042837
work_keys_str_mv AT mcnuttpatrick architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT lymanmegan architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT swartzadam architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT tuznikkaylie architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT kniffindenise architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT whittenkim architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT milhorndenise architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms
AT hamiltontracey architecturalandbiochemicalexpressionsofmustardgaskeratopathypreclinicalindicatorsandpathogenicmechanisms